CME
Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis
November 20, 2020
Host: Ruben A. Mesa, MD, FACP
The only potentially curative therapy for Myelofibrosis (MF) is hematopoietic stem cell transplantation (HSCT), applicable only to patients with a compatible donor, and of suitable age and functional status to withstand
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!